(19)
(11) EP 3 107 563 A2

(12)

(88) Date of publication A3:
14.01.2016

(43) Date of publication:
28.12.2016 Bulletin 2016/52

(21) Application number: 15744656.8

(22) Date of filing: 20.02.2015
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
A61K 47/48(2006.01)
(86) International application number:
PCT/IB2015/001145
(87) International publication number:
WO 2015/140648 (24.09.2015 Gazette 2015/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 21.02.2014 US 201461942942 P

(71) Applicants:
  • Ecole Polytechnique Fédérale de Lausanne (EPFL) EPFL-TTO
    1015 Lausanne (CH)
  • Anokion SA
    1024 Ecublens (CH)

(72) Inventors:
  • HUBBELL, Jeffrey A.
    Chicago, IL 60615-1915 (US)
  • KONTOS, Stephane
    CH-1022 Chavannes-pres-Renens (CH)
  • LORENTZ, Kristen Marie
    CH-1022 Chavannes-pres-Renens (CH)
  • WILSON, David Scott
    CH-1007 Lausanne (CH)
  • GAI, Shuning
    CH-1196 Gland (CH)

(74) Representative: Zwicker, Jörk 
ZSP Patentanwälte PartG mbB Radlkoferstrasse 2
81373 München
81373 München (DE)

   


(54) GLYCOTARGETING THERAPEUTICS